Published in J Virol on May 01, 1990
Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants. J Virol (1990) 3.05
Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection. J Virol (2008) 1.88
Functional order of assembly of herpes simplex virus DNA replication proteins into prereplicative site structures. J Virol (1996) 1.78
ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. J Virol (1998) 1.75
Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes. J Virol (1996) 1.61
Herpes simplex virus type 1 prereplicative sites are a heterogeneous population: only a subset are likely to be precursors to replication compartments. J Virol (1997) 1.56
Correct intranuclear localization of herpes simplex virus DNA polymerase requires the viral ICP8 DNA-binding protein. J Virol (1991) 1.55
"The end of innocence" revisited: resistance of herpesviruses to antiviral drugs. Clin Microbiol Rev (1994) 1.54
Effects of mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene on enzyme activities, viral replication, and replication fidelity. J Virol (1997) 1.46
Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype. J Virol (1991) 1.43
The extreme C terminus of herpes simplex virus DNA polymerase is crucial for functional interaction with processivity factor UL42 and for viral replication. J Virol (1993) 1.43
Engineered herpes simplex virus DNA polymerase point mutants: the most highly conserved region shared among alpha-like DNA polymerases is involved in substrate recognition. J Virol (1990) 1.41
Characterization of nuclear structures in cells infected with herpes simplex virus type 1 in the absence of viral DNA replication. J Virol (1996) 1.38
A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc Natl Acad Sci U S A (1994) 1.26
Translational regulation of herpes simplex virus DNA polymerase. J Virol (1990) 1.21
Identification and functional characterization of Epstein-Barr virus DNA polymerase by in vitro transcription-translation of a cloned gene. J Virol (1991) 1.18
Virus-Induced Chaperone-Enriched (VICE) domains function as nuclear protein quality control centers during HSV-1 infection. PLoS Pathog (2009) 1.11
Oligomerization of ICP4 and rearrangement of heat shock proteins may be important for herpes simplex virus type 1 prereplicative site formation. J Virol (2008) 1.10
Interactions of herpes simplex virus type 1 with ND10 and recruitment of PML to replication compartments. J Virol (2001) 1.09
Polymerization activity of an alpha-like DNA polymerase requires a conserved 3'-5' exonuclease active site. Mol Cell Biol (1991) 1.09
Nucleolin is required for an efficient herpes simplex virus type 1 infection. J Virol (2008) 1.07
Effects of exonuclease activity and nucleotide selectivity of the herpes simplex virus DNA polymerase on the fidelity of DNA replication in vivo. J Virol (1999) 1.00
Two regions of the herpes simplex virus type 1 UL42 protein are required for its functional interaction with the viral DNA polymerase. J Virol (1993) 0.97
Characterization of mre11 loss following HSV-1 infection. Virology (2008) 0.88
Conformational changes induced in herpes simplex virus DNA polymerase upon DNA binding. Proc Natl Acad Sci U S A (1993) 0.88
Exonuclease-deficient polymerase mutant of herpes simplex virus type 1 induces altered spectra of mutations. J Virol (2003) 0.87
Unusual regulation of expression of the herpes simplex virus DNA polymerase gene. J Virol (1993) 0.85
Conformational changes in the herpes simplex virus ICP8 DNA-binding protein coincident with assembly in viral replication structures. J Virol (2003) 0.84
Co-opting the Fanconi anemia genomic stability pathway enables herpesvirus DNA synthesis and productive growth. Mol Cell (2014) 0.83
Mutations that increase DNA binding by the processivity factor of herpes simplex virus affect virus production and DNA replication fidelity. J Virol (2009) 0.82
Assessing the contribution of the herpes simplex virus DNA polymerase to spontaneous mutations. BMC Infect Dis (2002) 0.82
Herpes simplex virus type 1 single strand DNA binding protein and helicase/primase complex disable cellular ATR signaling. PLoS Pathog (2013) 0.82
Finger domain mutation affects enzyme activity, DNA replication efficiency, and fidelity of an exonuclease-deficient DNA polymerase of herpes simplex virus type 1. J Virol (2009) 0.81
Codon optimization enhances protein expression of Bombyx mori nucleopolyhedrovirus DNA polymerase in E. coli. Curr Microbiol (2013) 0.79
Inhibition of translation by a short element in the 5' leader of the herpes simplex virus 1 DNA polymerase transcript. J Virol (2007) 0.78
H2AX phosphorylation and DNA damage kinase activity are dispensable for herpes simplex virus replication. Virol J (2016) 0.77
Direct evidence that HSV DNA damaged by ultraviolet (UV) irradiation can be repaired in a cell type-dependent manner. J Neurovirol (2012) 0.77
Kinetic approaches to understanding the mechanisms of fidelity of the herpes simplex virus type 1 DNA polymerase. J Nucleic Acids (2010) 0.75
Viral Ubiquitin Ligase Stimulates Selective Host MicroRNA Expression by Targeting ZEB Transcriptional Repressors. Viruses (2017) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Genomic sequencing. Proc Natl Acad Sci U S A (1984) 92.36
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79
The scanning model for translation: an update. J Cell Biol (1989) 31.23
Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol (1985) 13.99
The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA. Nucleic Acids Res (1985) 12.11
Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol (1985) 8.12
Cloning of herpes simplex virus type 1 sequences representing the whole genome. J Virol (1981) 5.66
Temperature-sensitive mutants of herpes simplex virus type 1: isolation, complementation and partial characterization. Virology (1973) 5.10
DNA sequence of the region in the genome of herpes simplex virus type 1 containing the genes for DNA polymerase and the major DNA binding protein. Nucleic Acids Res (1985) 4.84
A method for identifying the viral genes required for herpesvirus DNA replication. Proc Natl Acad Sci U S A (1986) 4.61
DNA synthesis and DNA polymerase activity of herpes simplex virus type 1 temperature-sensitive mutants. J Virol (1975) 4.31
Collaborative complementation study of temperature-sensitive mutants of herpes simplex virus types 1 and 2. J Virol (1978) 4.31
Cloning, sequencing, and functional analysis of oriL, a herpes simplex virus type 1 origin of DNA synthesis. Mol Cell Biol (1985) 4.14
Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45. J Virol (1984) 4.09
Sequence and mapping analyses of the herpes simplex virus DNA polymerase gene predict a C-terminal substrate binding domain. Proc Natl Acad Sci U S A (1985) 3.47
Related functional domains in virus DNA polymerases. EMBO J (1987) 3.35
Herpes simplex virus resistance and sensitivity to phosphonoacetic acid. J Virol (1977) 3.32
Identification of the herpes simplex virus DNA polymerase gene. Nature (1977) 3.05
Regulation of protein synthesis in virus-infected animal cells. Adv Virus Res (1986) 2.93
A genetic approach to promoter recognition during trans induction of viral gene expression. Science (1986) 2.77
Genetic analysis of temperature-sensitive mutants of HSV-1: the combined use of complementation and physical mapping for cistron assignment. Virology (1983) 2.66
Properties of herpes simplex virus DNA polymerase and characterization of its associated exonuclease activity. Eur J Biochem (1979) 2.55
Fine mapping and molecular cloning of mutations in the herpes simplex virus DNA polymerase locus. J Virol (1984) 2.51
Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc Natl Acad Sci U S A (1988) 2.27
Physical and genetic analysis of the herpes simplex virus DNA polymerase locus. Virology (1980) 2.11
Mutations in the herpes simplex virus major DNA-binding protein gene leading to altered sensitivity to DNA polymerase inhibitors. Virology (1985) 2.05
Herpes simplex virus DNA polymerase as the site of phosphonoacetate sensitivity: temperature-sensitive mutants. J Virol (1977) 1.81
Properties of herpes simplex virus type 1 and type 2 DNA polymerase. Biochim Biophys Acta (1980) 1.71
Vaccinia virus vectors utilizing the beta-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression. Gene (1986) 1.64
Temperature-sensitive mutants in two distinct complementation groups of herpes simplex virus type 1 specify thermolabile DNA polymerase. J Gen Virol (1981) 1.53
Genome locations of temperature-sensitive mutants in glycoprotein gB of herpes simplex virus type 1. Virology (1984) 1.45
Analysis of the transcript of the herpes simplex virus DNA polymerase gene provides evidence that polymerase expression is inefficient at the level of translation. J Virol (1988) 1.43
A single-base change within the DNA polymerase locus of herpes simplex virus type 2 can confer resistance to aphidicolin. J Virol (1987) 1.39
Effect of an amber mutation in the herpes simplex virus thymidine kinase gene on polypeptide synthesis and stability. Virology (1989) 1.35
Herpes simplex virus type 1 DNA synthesis requires the product of the UL8 gene: isolation and characterization of an ICP6::lacZ insertion mutation. J Virol (1989) 1.21
Translational regulation of herpes simplex virus DNA polymerase. J Virol (1990) 1.21
Nucleotide sequence of the DNA polymerase gene of herpes simplex virus type 1 strain Angelotti. Nucleic Acids Res (1986) 1.11
Examination of the roles of transcription factor Sp1-binding sites and an octamer motif in trans induction of the herpes simplex virus thymidine kinase gene. J Virol (1989) 1.11
Restoration of wild-type pathogenicity to an attenuated DNA polymerase mutant of herpes simplex virus type 1. J Gen Virol (1986) 1.00
General aspects of virus drug resistance with special reference to herpes simplex virus. J Antimicrob Chemother (1986) 0.88
Structural organization and unusual codon usage in the DNA polymerase gene from herpes simplex virus type 1. DNA (1986) 0.86
Functional expression of a cloned herpes simplex virus type 1 DNA polymerase gene. J Virol (1987) 0.84
Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol (1989) 5.77
Maize plastid gene expressed during photoregulated development. Proc Natl Acad Sci U S A (1978) 5.02
A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J Virol (1989) 4.85
A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature (1992) 3.59
Sequence and mapping analyses of the herpes simplex virus DNA polymerase gene predict a C-terminal substrate binding domain. Proc Natl Acad Sci U S A (1985) 3.47
The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol (1993) 3.43
Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proc Natl Acad Sci U S A (1980) 3.32
Membrane proteins synthesized but not processed by isolated maize chloroplasts. J Cell Biol (1978) 3.31
Differential expression of the gene for the large subunit of ribulose bisphosphate carboxylase in maize leaf cell types. Cell (1978) 3.21
Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J Virol (1995) 3.18
Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science (1991) 3.14
Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants. J Virol (1990) 3.05
A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J Virol (1997) 2.83
The herpes simplex virus type 1 UL42 gene product: a subunit of DNA polymerase that functions to increase processivity. J Virol (1990) 2.79
A genetic approach to promoter recognition during trans induction of viral gene expression. Science (1986) 2.77
Genetic analysis of temperature-sensitive mutants of HSV-1: the combined use of complementation and physical mapping for cistron assignment. Virology (1983) 2.66
A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J Virol (1999) 2.58
Fine mapping and molecular cloning of mutations in the herpes simplex virus DNA polymerase locus. J Virol (1984) 2.51
Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc Natl Acad Sci U S A (1988) 2.27
Generation of genetic diversity in herpes simplex virus: an antimutator phenotype maps to the DNA polymerase locus. Virology (1984) 2.19
Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus. J Virol (1985) 2.18
A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Antimicrob Agents Chemother (1993) 2.16
Location of the single gene for the large subunit of ribulosebisphosphate carboxylase on the maize chloroplast chromosome. J Biol Chem (1979) 2.12
A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. Virology (1989) 2.10
The crystal structure of an unusual processivity factor, herpes simplex virus UL42, bound to the C terminus of its cognate polymerase. Mol Cell (2000) 2.09
Promoter domains required for expression of plasmid-borne copies of the herpes simplex virus thymidine kinase gene in virus-infected mouse fibroblasts and microinjected frog oocytes. Mol Cell Biol (1985) 2.09
The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J Virol (1997) 2.06
Mutations in the herpes simplex virus major DNA-binding protein gene leading to altered sensitivity to DNA polymerase inhibitors. Virology (1985) 2.05
Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J Virol (1993) 2.01
A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture. J Virol (1989) 1.95
Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine. J Virol (1982) 1.79
Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity? Ann Intern Med (1989) 1.78
A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate. Proc Natl Acad Sci U S A (1986) 1.78
ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. J Virol (1998) 1.75
Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities. J Virol (1981) 1.74
Mutations in the herpes simplex virus DNA polymerase gene conferring hypersensitivity to aphidicolin. Nucleic Acids Res (1983) 1.56
Correct intranuclear localization of herpes simplex virus DNA polymerase requires the viral ICP8 DNA-binding protein. J Virol (1991) 1.55
Interleukin-1alpha and collagenase activity are elevated in chronic wounds. Plast Reconstr Surg (1998) 1.54
A novel functional domain of an alpha-like DNA polymerase. The binding site on the herpes simplex virus polymerase for the viral UL42 protein. J Biol Chem (1990) 1.54
Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus. J Virol (1998) 1.52
Enzymatic activities of overexpressed herpes simplex virus DNA polymerase purified from recombinant baculovirus-infected insect cells. Nucleic Acids Res (1990) 1.49
Tissue-specific forms of actin in the developing chick. Cell (1976) 1.49
Effects of mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene on enzyme activities, viral replication, and replication fidelity. J Virol (1997) 1.46
Demonstration of circularization of herpes simplex virus DNA following infection using pulsed field gel electrophoresis. Virology (1993) 1.46
A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance. J Virol (1992) 1.44
Analysis of the transcript of the herpes simplex virus DNA polymerase gene provides evidence that polymerase expression is inefficient at the level of translation. J Virol (1988) 1.43
The extreme C terminus of herpes simplex virus DNA polymerase is crucial for functional interaction with processivity factor UL42 and for viral replication. J Virol (1993) 1.43
Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation. Virology (2000) 1.42
Engineered herpes simplex virus DNA polymerase point mutants: the most highly conserved region shared among alpha-like DNA polymerases is involved in substrate recognition. J Virol (1990) 1.41
Importance of the herpes simplex virus UL24 gene for productive ganglionic infection in mice. Virology (1998) 1.40
Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir. Neurosurgery (1993) 1.39
Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein. Antimicrob Agents Chemother (1999) 1.38
Herpes simplex virus transactivator ICP4 operationally substitutes for the cellular transcription factor Sp1 for efficient expression of the viral thymidine kinase gene. J Virol (1991) 1.37
MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res (1999) 1.37
Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses. J Virol (1990) 1.35
Effect of an amber mutation in the herpes simplex virus thymidine kinase gene on polypeptide synthesis and stability. Virology (1989) 1.35
The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg (1996) 1.30
Isolation of foscarnet-resistant human cytomegalovirus patterns of resistance and sensitivity to other antiviral drugs. J Infect Dis (1991) 1.29
Translational recoding induced by G-rich mRNA sequences that form unusual structures. Cell (1996) 1.29
A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc Natl Acad Sci U S A (1994) 1.26
Functional analysis of the herpes simplex virus UL42 protein. J Virol (1993) 1.25
Comparative efficacy of expression of genes delivered to mouse sensory neurons with herpes virus vectors. J Comp Neurol (1994) 1.21
Translational regulation of herpes simplex virus DNA polymerase. J Virol (1990) 1.21
Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J Biol Chem (1997) 1.20
Mutations that specifically impair the DNA binding activity of the herpes simplex virus protein UL42. J Virol (1995) 1.19
Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene. J Virol (1986) 1.17
A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature (1992) 1.16
Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis? J Infect Dis (1998) 1.13
Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia. J Virol (1993) 1.13
Specific inhibition of herpes simplex virus DNA polymerase by helical peptides corresponding to the subunit interface. Proc Natl Acad Sci U S A (1995) 1.13
Structural and functional organization of herpes simplex virus DNA polymerase investigated by limited proteolysis. J Biol Chem (1994) 1.13
Examination of the roles of transcription factor Sp1-binding sites and an octamer motif in trans induction of the herpes simplex virus thymidine kinase gene. J Virol (1989) 1.11
Polymerization activity of an alpha-like DNA polymerase requires a conserved 3'-5' exonuclease active site. Mol Cell Biol (1991) 1.09
Interactions of herpes simplex virus type 1 with ND10 and recruitment of PML to replication compartments. J Virol (2001) 1.09
Specific inhibitors of herpes simplex virus thymidine kinase diminish reactivation of latent virus from explanted murine ganglia. Antimicrob Agents Chemother (1990) 1.08
Physiology of the chronic wound. Clin Plast Surg (1998) 1.07
The role of herpes simplex virus ICP27 in the regulation of UL24 gene expression by differential polyadenylation. J Virol (1998) 1.05
Alternate utilization of two regulatory domains within the Moloney murine sarcoma virus long terminal repeat. Mol Cell Biol (1985) 1.04
Molecular mechanisms of antiviral resistance. Antiviral Res (1995) 1.03
Linear diffusion on DNA despite high-affinity binding by a DNA polymerase processivity factor. Mol Cell (2001) 1.00
The enzymological basis for resistance of herpesvirus DNA polymerase mutants to acyclovir: relationship to the structure of alpha-like DNA polymerases. Proc Natl Acad Sci U S A (1999) 0.98
Regulation of neighboring gene expression by the herpes simplex virus type 1 thymidine kinase gene. Virology (1996) 0.96
Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1. Am J Med (1982) 0.96
Temporal regulation of herpes simplex virus type 1 UL24 mRNA expression via differential polyadenylation. Virology (1996) 0.96
Dynamics of the matrix metalloproteinases MMP-1 and MMP-8 in acute open human dermal wounds. Wound Repair Regen (1999) 0.94
Lower cytokine release by fetal porcine platelets: a possible explanation for reduced inflammation after fetal wounding. J Pediatr Surg (1996) 0.94
Marke's disease herpesviruses. III. Purification and characterization of Marek's disease herpesvirus B antigen. J Virol (1978) 0.94
Secondary structure and structure-activity relationships of peptides corresponding to the subunit interface of herpes simplex virus DNA polymerase. J Biol Chem (2000) 0.93
Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922). Antimicrob Agents Chemother (1998) 0.93
Penciclovir and pathogenesis phenotypes of drug-resistant Herpes simplex virus mutants. Antiviral Res (1998) 0.92
A herpes simplex virus DNA polymerase mutation that specifically attenuates neurovirulence in mice. Virology (1998) 0.92
The role of inflammatory cytokines in wound healing: accelerated healing in endotoxin-resistant mice. J Trauma (1994) 0.92
CNS tumor therapy by attenuated herpes simplex viruses. Gene Ther (1994) 0.92
Dexamethasone abrogates the fibrogenic effect of transforming growth factor-beta in rat granuloma and granulation tissue fibroblasts. J Invest Dermatol (1997) 0.91